• Institute of Good Manufacturing Practices India
  • Global accredited training & certification provider
  • Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India
  • Approved Training Institute of Food Safety and Standards Authority of India (FSSAI)
  • Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India
  • An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India
  • Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh
  • Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC) set up by National Skill Development Corporation (NSDC)
  • Conferred with QUALITY COUNCIL OF INDIA (QCI) – D.L. SHAH NATIONAL QUALITY AWARD & ASSOCHAM Services Excellence Award 2017

Trusted by organizations & training participants in over 30 countries
Training | Certification | Education | Research


Drug recall in US market by Lupin and Aurobindo Pharma

Updated: 31 March 2019

Deviations related with Current Good Manufacturing Practice regulations were observed for Aurobindo Pharma leading them to recall several lots of drugs involved in lowering blood pressure, Valsartan. Similarly, Lupin has also recalled Testosterone Topical solution bottles due to container issues observed by USFDA.

The drug recall of Valsartan has classified as Class II recall which starts in condition where the utilization or exposure of violated product can lead to medically reversible or temporary adverse health consequences or there are remote chances of severe adverse health consequences.

Repeated complaints regarding faulty pumps were received by USFDA for Lupin’s Testosterone Topical solution resulting into product recall. This recall comes as Class III which starts in a condition where use or exposure of violated product does not lead to any adverse health consequence.